Topic
infectious-disease-prevention
1 stories related to this topic, newest first.
Usa Todayhealth7 hrs agoFraming55Framing risk55/100Rewrite largely reports trial data neutrally but inherits mild valence skew and lede misdirection by foregrounding the 'beats standard shot' victory frame and regulatory drama over balanced efficacy/safety substance.Click to jump to full framing analysis
Moderna mRNA Flu Vaccine Outperforms Standard Shot in Phase 3 Trial
Moderna's mRNA-based seasonal flu vaccine proved 26.6 percent more effective than a conventional flu shot in a trial of more than 40,000 adults aged 50 and older. Results from the Phase 3 study were published Wednesday in the New England Journal of Medicine. The vaccine awaits a…